Literature DB >> 33294279

Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer.

Jun Zou1, Wan Qin1, Lin Yang1, Lulu Wang2, Yu Wang3, Jianfeng Shen4, Wei Xiong5, Shiying Yu1, Shumei Song6, Jaffer A Ajani6, Shiaw-Yih Lin7, Gordon B Mills8, Xianglin Yuan1, Jianying Chen9, Guang Peng2.   

Abstract

The AT-rich Interactive Domain 1A (ARID1A) is one of the most frequently mutated genes in gastric cancer. Here, we found that genetic variants in noncoding regions of ARID1A associated with altered protein levels by target sequencing. Notably, tumors with ARID1A variants in the 3'untranslated region (3'UTR) exhibited remarkably increased heterogeneity of ARID1A protein. In general, genetic variants and protein deficiency of ARID1A in tumors were associated with a better survival. Strikingly, altered patterns and heterogeneity of ARID1A protein expression were observed in peritumor tissues and carried significant implications in defining tumor immune contexture by multiplex immunohistochemistry. By analyzing the spatial distribution of TILs, we showed that reduced ARID1A protein levels in both tumor and peritumor tissues were significantly correlated with increased density and proximity of TILs to tumor cells. In contrast, high heterogeneity of ARID1A expression was associated with increased TIL density, but reduced proximity of TILs to tumor cells. Collectively, our study characterized ARID1A genetic alterations and its protein expression patterns in EOGC, demonstrating new strategies for clinically assessing its molecular impact on tumor onset and progression, tumor immune response, and patient survival. AJCR
Copyright © 2020.

Entities:  

Keywords:  ARID1A; early-onset gastric cancer; heterogeneity; target sequencing; tumor immune contexture

Year:  2020        PMID: 33294279      PMCID: PMC7716160     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  60 in total

1.  Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

Authors:  Eleftherios P Samartzis; Nicolas Samartzis; Aurelia Noske; André Fedier; Rosmarie Caduff; Konstantin J Dedes; Daniel Fink; Patrick Imesch
Journal:  Mod Pathol       Date:  2012-02-03       Impact factor: 7.842

Review 2.  Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.

Authors:  Roodolph St Pierre; Cigall Kadoch
Journal:  Curr Opin Genet Dev       Date:  2017-04-06       Impact factor: 5.578

3.  ARID1A mutations in endometriosis-associated ovarian carcinomas.

Authors:  Kimberly C Wiegand; Sohrab P Shah; Osama M Al-Agha; Yongjun Zhao; Kane Tse; Thomas Zeng; Janine Senz; Melissa K McConechy; Michael S Anglesio; Steve E Kalloger; Winnie Yang; Alireza Heravi-Moussavi; Ryan Giuliany; Christine Chow; John Fee; Abdalnasser Zayed; Leah Prentice; Nataliya Melnyk; Gulisa Turashvili; Allen D Delaney; Jason Madore; Stephen Yip; Andrew W McPherson; Gavin Ha; Lynda Bell; Sian Fereday; Angela Tam; Laura Galletta; Patricia N Tonin; Diane Provencher; Dianne Miller; Steven J M Jones; Richard A Moore; Gregg B Morin; Arusha Oloumi; Niki Boyd; Samuel A Aparicio; Ie-Ming Shih; Anne-Marie Mes-Masson; David D Bowtell; Martin Hirst; Blake Gilks; Marco A Marra; David G Huntsman
Journal:  N Engl J Med       Date:  2010-09-08       Impact factor: 91.245

4.  Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.

Authors:  Cécile Guichard; Giuliana Amaddeo; Sandrine Imbeaud; Yannick Ladeiro; Laura Pelletier; Ichrafe Ben Maad; Julien Calderaro; Paulette Bioulac-Sage; Mélanie Letexier; Françoise Degos; Bruno Clément; Charles Balabaud; Eric Chevet; Alexis Laurent; Gabrielle Couchy; Eric Letouzé; Fabien Calvo; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

5.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

6.  ARID1A spatially partitions interphase chromosomes.

Authors:  Shuai Wu; Nail Fatkhutdinov; Leah Rosin; Jennifer M Luppino; Osamu Iwasaki; Hideki Tanizawa; Hsin-Yao Tang; Andrew V Kossenkov; Alessandro Gardini; Ken-Ichi Noma; David W Speicher; Eric F Joyce; Rugang Zhang
Journal:  Sci Adv       Date:  2019-05-22       Impact factor: 14.136

7.  SWI/SNF component ARID1A restrains pancreatic neoplasia formation.

Authors:  Sam C Wang; Ibrahim Nassour; Shu Xiao; Shuyuan Zhang; Xin Luo; Jeon Lee; Lin Li; Xuxu Sun; Liem H Nguyen; Jen-Chieh Chuang; Lan Peng; Scott Daigle; Jeanne Shen; Hao Zhu
Journal:  Gut       Date:  2018-10-12       Impact factor: 23.059

8.  ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.

Authors:  Mike R Wilson; Jake J Reske; Jeanne Holladay; Genna E Wilber; Mary Rhodes; Julie Koeman; Marie Adams; Ben Johnson; Ren-Wei Su; Niraj R Joshi; Amanda L Patterson; Hui Shen; Richard E Leach; Jose M Teixeira; Asgerally T Fazleabas; Ronald L Chandler
Journal:  Nat Commun       Date:  2019-08-07       Impact factor: 14.919

9.  ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.

Authors:  Chris T Williamson; Rowan Miller; Helen N Pemberton; Samuel E Jones; James Campbell; Asha Konde; Nicholas Badham; Rumana Rafiq; Rachel Brough; Aditi Gulati; Colm J Ryan; Jeff Francis; Peter B Vermulen; Andrew R Reynolds; Philip M Reaper; John R Pollard; Alan Ashworth; Christopher J Lord
Journal:  Nat Commun       Date:  2016-12-13       Impact factor: 14.919

10.  Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.

Authors:  Soo Young Cho; Jun Won Park; Yang Liu; Young Soo Park; Ju Hee Kim; Hanna Yang; Hyejin Um; Woo Ri Ko; Byung Il Lee; Sun Young Kwon; Seung Wan Ryu; Chae Hwa Kwon; Do Youn Park; Jae-Hyuk Lee; Sang Il Lee; Kyu Sang Song; Hoon Hur; Sang-Uk Han; Heekyung Chang; Su-Jin Kim; Byung-Sik Kim; Jeong-Hwan Yook; Moon-Won Yoo; Beom-Su Kim; In-Seob Lee; Myeong-Cherl Kook; Nina Thiessen; An He; Chip Stewart; Andrew Dunford; Jaegil Kim; Juliann Shih; Gordon Saksena; Andrew D Cherniack; Steven Schumacher; Amaro-Taylor Weiner; Mara Rosenberg; Gad Getz; Eun Gyeong Yang; Min-Hee Ryu; Adam J Bass; Hark Kyun Kim
Journal:  Gastroenterology       Date:  2017-05-15       Impact factor: 33.883

View more
  5 in total

1.  Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.

Authors:  Xuan Wang; Keying Che; Tao Shi; Qin Liu; Xinyun Xu; Hongyan Wu; Lixia Yu; Baorui Liu; Jia Wei
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-16       Impact factor: 4.553

2.  Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.

Authors:  Ting Wang; Chuan Liu; Wancong Wang; Binglu Huang; Rong Yu; Mengting Huang; Weiguo Dong
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

3.  A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old.

Authors:  Qian Huang; Xiufeng Zheng; Yang Jiao; Yanna Lei; Xiaoying Li; Feng Bi; Fukun Guo; Gang Wang; Ming Liu
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

4.  Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis.

Authors:  Hanqiang Wu; Jianrong Liang
Journal:  J Cell Mol Med       Date:  2021-10-21       Impact factor: 5.310

5.  SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization.

Authors:  Jiangchun Wu; Yong Wu; Qinhao Guo; Xiaohua Wu; Jun Zhu; Xingzhu Ju; Siyu Chen; Simin Wang
Journal:  J Transl Med       Date:  2022-08-30       Impact factor: 8.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.